LI
ANIP icon

LRI Investments’s ANI Pharmaceuticals ANIP Stock Holding History

LRI Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.3K Sell
52
-26
-33% -$2.09K ﹤0.01% 1170
2026
Q1 		$6K Hold
78
– – ﹤0.01% 1034
2025
Q4 		$6.19K Buy
78
+12
+18% +$1.04K ﹤0.01% 994
2025
Q3 		$6.01K Hold
66
– – ﹤0.01% 1002
2025
Q2 		$4.28K Hold
66
– – ﹤0.01% 1053
2025
Q1 		$4.39K Hold
66
– – ﹤0.01% 980
2024
Q4 		$3.63K Hold
66
– – ﹤0.01% 990
2024
Q3 		$3.87K Buy
+66
New +$4.03K ﹤0.01% 982

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LRI Investments's ANIP Position: Q2 2026 in Review

LRI Investments reduced its ANI Pharmaceuticals (ANIP) stake by 33% in Q2 2026, selling an estimated $2.09K and leaving 52 shares worth $4.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1170.

LRI Investments first reported a position in ANIP in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.19K in Q4 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • LRI Investments held 52 shares of ANI Pharmaceuticals worth $4.3K as of Q2 2026.
  • LRI Investments sold 26 ANI Pharmaceuticals shares in Q2 2026, an estimated $2.09K.
  • ANI Pharmaceuticals made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1170 holding.
  • LRI Investments first reported a position in ANI Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • LRI Investments's ANI Pharmaceuticals position peaked at $6.19K in Q4 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.